Angle

Angle company information, Employees & Contact Information

Explore related pages

Related company profiles:

ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. The clinical services business is offered through ANGLE’s GCP-compliant laboratories in the UK and the United States. Services include custom made assay development and clinical trial testing for the pharmaceutical industry. Over 80 peer-reviewed publications have demonstrated the performance of the Parsortix system. For more information, visit www.angleplc.com

Company Details

Employees
183
Founded
-
Address
10 Nugent Road, Surrey Research Park,england Gu2 7af,united Kingdom
Phone
+44 1483 685830
Email
en****@****plc.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Surrey Research Park, England
Looking for a particular Angle employee's phone or email?

Angle Questions

News

ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor - Yahoo Finance

ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor Yahoo Finance

ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor - Stock Titan

ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor Stock Titan

Angle PLC Announces Strategy Update - ACCESS Newswire

Angle PLC Announces Strategy Update ACCESS Newswire

Angle PLC Announces Interim Results - Yahoo Finance

Angle PLC Announces Interim Results Yahoo Finance

Angle PLC Announces Board Changes | Markets - Medicine Hat NewsMedicine Hat News - FinancialContent

Angle PLC Announces Board Changes | Markets - Medicine Hat NewsMedicine Hat News FinancialContent

Cash runway to Q1 2026: ANGLE plc appoints Executive Chairman and proposes CelLBxHealth name - Stock Titan

Cash runway to Q1 2026: ANGLE plc appoints Executive Chairman and proposes CelLBxHealth name Stock Titan

Leading Liquid Biopsy Company ANGLE PLC to Present H1 2025 Results with Virtual Analyst Meeting - Stock Titan

Leading Liquid Biopsy Company ANGLE PLC to Present H1 2025 Results with Virtual Analyst Meeting Stock Titan

Angle PLC Announces Trading Update - FinancialContent

Angle PLC Announces Trading Update FinancialContent

Angle PLC Announces Presentation of Data on Glioblastoma - ACCESS Newswire

Angle PLC Announces Presentation of Data on Glioblastoma ACCESS Newswire

Angle PLC Announces Change of Adviser - Yahoo Finance

Angle PLC Announces Change of Adviser Yahoo Finance

Angle PLC Announces Board Changes - Stock Titan

Angle PLC Announces Board Changes Stock Titan

Angle PLC Announces Board Changes - Yahoo Finance

Angle PLC Announces Board Changes Yahoo Finance

Major Board Shake-up at ANGLE as Two Directors Exit: 12-Year Veteran Retires, Another Makes Sudden Departure - Stock Titan

Major Board Shake-up at ANGLE as Two Directors Exit: 12-Year Veteran Retires, Another Makes Sudden Departure Stock Titan

ANGLE plc Announces Novel Discoveries Into the Biology of Cancer - Yahoo Finance

ANGLE plc Announces Novel Discoveries Into the Biology of Cancer Yahoo Finance

Angle PLC Announces Board Change - Appointment of New Chairman - ACCESS Newswire

Angle PLC Announces Board Change - Appointment of New Chairman ACCESS Newswire

Angle PLC Announces Change of Adviser - ACCESS Newswire

Angle PLC Announces Change of Adviser ACCESS Newswire

ANGLE Announces Collaboration with Myriad Genetics - Yahoo Finance

ANGLE Announces Collaboration with Myriad Genetics Yahoo Finance

60% Detection Rate: ANGLE's Breakthrough in Brain Cancer Liquid Biopsy Outperforms DNA Testing - Stock Titan

60% Detection Rate: ANGLE's Breakthrough in Brain Cancer Liquid Biopsy Outperforms DNA Testing Stock Titan

Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies - Yahoo Finance

Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies Yahoo Finance

Angle PLC Announces Streamlining of Operations to Increase Cash Runway - Yahoo Finance

Angle PLC Announces Streamlining of Operations to Increase Cash Runway Yahoo Finance

Angle PLC Announces Issue of LTIP Options and Share Options - Yahoo Finance

Angle PLC Announces Issue of LTIP Options and Share Options Yahoo Finance

ANGLE Announces Key June 30 AGM, 2024 Annual Report Now Available for Liquid Biopsy Innovation - Stock Titan

ANGLE Announces Key June 30 AGM, 2024 Annual Report Now Available for Liquid Biopsy Innovation Stock Titan

Angle PLC Announces Pharma Services Contract with Crescendo Biologics - Yahoo Finance

Angle PLC Announces Pharma Services Contract with Crescendo Biologics Yahoo Finance

Major Cancer Discovery: Scientists Uncover How Tumors Spread During Surgery in Groundbreaking Research - Stock Titan

Major Cancer Discovery: Scientists Uncover How Tumors Spread During Surgery in Groundbreaking Research Stock Titan

ANGLE Transforms Business with 31% Revenue Jump and Major Pharma Deals in Liquid Biopsy Market - Stock Titan

ANGLE Transforms Business with 31% Revenue Jump and Major Pharma Deals in Liquid Biopsy Market Stock Titan

Breakthrough in Cancer Testing: ANGLE and Myriad Genetics Join Forces for Blood-Based Diagnostic Solution - Stock Titan

Breakthrough in Cancer Testing: ANGLE and Myriad Genetics Join Forces for Blood-Based Diagnostic Solution Stock Titan

ANGLE PLC (ANPCY) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

ANGLE PLC (ANPCY) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... Yahoo Finance

Angle PLC Announces Parsortix Enables Study Of Cancer Progression - ACCESS Newswire

Angle PLC Announces Parsortix Enables Study Of Cancer Progression ACCESS Newswire

Angle PLC Announces Exclusive agreement for DNA NGS panel - Stock Titan

Angle PLC Announces Exclusive agreement for DNA NGS panel Stock Titan

Angle PLC Announces First Large-Scale Pharma Services Contract Secured - ACCESS Newswire

Angle PLC Announces First Large-Scale Pharma Services Contract Secured ACCESS Newswire

Angle PLC Announces Issue of Equity - ACCESS Newswire

Angle PLC Announces Issue of Equity ACCESS Newswire

DCCNet demonstrates use of Parsortix system for single cell CTC analysis - News-Medical

DCCNet demonstrates use of Parsortix system for single cell CTC analysis News-Medical

The Parsortix™ Cell Separation System—A versatile liquid biopsy platform - Miller - 2018 - Cytometry Part A - Wiley Online Library

The Parsortix™ Cell Separation System—A versatile liquid biopsy platform - Miller - 2018 - Cytometry Part A Wiley Online Library

$4.02 Billion Growth in Liquid Biopsy Market During 2020-2024 | Featuring ANGLE Plc and Biocept Inc. Among Others | Technavio - Business Wire

$4.02 Billion Growth in Liquid Biopsy Market During 2020-2024 | Featuring ANGLE Plc and Biocept Inc. Among Others | Technavio Business Wire

Angle PLC Announces Breakthrough Research with Parsortix - ACCESS Newswire

Angle PLC Announces Breakthrough Research with Parsortix ACCESS Newswire

More gain, less pain with liquid biopsies - Laboratory News

More gain, less pain with liquid biopsies Laboratory News

Angle PLC Announces Acquisition of Outstanding Shares - ACCESS Newswire

Angle PLC Announces Acquisition of Outstanding Shares ACCESS Newswire

Top Angle Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant